[Current problems of antithrombotic therapy].
D000925:Anticoagulants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D010447:Peptide Hydrolases
Aktual'nye voprosy protivotromboticheskoĭ terapii.